AzTrials
AzTrials

Point of Care Ultrasonography in the Emergency Department.NCT02099045

Initial Patient Evaluation in the Emergency Department With Point-of-Care Ultrasonography

An observational study of Point of Care Ultrasonography in the Emergency Department., run by Aarhus University Hospital at 1 site in Denmark.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Background: It is well known that emergency physicians can conduct ultrasound examinations as a supplement to initial physical examination. No previous studies have been conducted to evaluate the total findings with ultrasound on a broad unselected group of patients in the Emergency Department. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Point of Care Ultrasonography
Type of treatment
Medical device
How many people
406 participants
Where
1 siteDenmark
Study dates
Apr 2014to Jan 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Unselected consecutive patients in the Emergency Department.

Who may be able to join

  • All patients over the age of 18 presenting at the ED

Who cannot join

  • Sonographic examination cannot be performed within the first two hours
  • Failure to consent.
  • Sonographical examination interferes with lifesaving treatment.

Trial locations and contacts

1 site in 1 country.

Jesper Weile, MD contact

(+45)22748072

jesper.weile@gmail.com

Denmark1 site, 1 recruiting
  • Emergency Department, Regional Hospital Herning

    Herning, 7400

    Jesper Bo Weile, MD, (+45)22748072

    Jesper B. Weile, MD

    Recruiting

Other trials in Denmark

About this study

Background: It is well known that emergency physicians can conduct ultrasound examinations as a supplement to initial physical examination. No previous studies have been conducted to evaluate the total findings with ultrasound on a broad unselected group of patients in the Emergency Department.

Aim: We aim to identify the pathology found in an unselected cohort of patients in a Rural Emergency Department. Secondarily we aim to quantify the changes done in treatment as a result of the ultrasound examination performed bedside in the Emergency Department.

Read more

Hypothesis: Supplemental ultrasonographical examination will change diagnostics and treatment in 10 % of an unselected cohort of patients in the Emergency Department.

Method: We will perform a structured ultrasound examination of 406 patients on an unselected cohort in the emergency department. All patients age 18 years and above presenting in the emergency department will be included in the study. Patients unwilling to give informed consent will be excluded from the study. Patients will be excluded if the ultrasonographic examination cannot be performed within the first two hours after initial contact with the treating physician. The study will be conducted in two substudies. Sub study 1 including all patient legally competent to give informed consent. Sub study 2 including all legally incompetent patients who cannot give informed consent due to acute illness. These patients will be included in the study under the rules of emergency research.

After including the patients we will ask the treating physician a series of binary questions regarding diagnosis and treatment plan.

Outcome: Primary outcome is the pathology found by ultrasound in the department. Secondary outcome will be the changes in diagnosis or treatment plan. Pathology and changes in diagnosis/treatment will be stratified according to initial complaint, triage level, age and other factors. This has never been done on unselected patients in the Emergency Department.

Ethical considerations and adverse effects: Ultrasound transmits high frequency waves into the tissue, which is reflected to the ultrasound probe. The time and magnitude of the returning sound waves are interpreted into picture on the screen. No adverse effects have been reported on the basis of the sound waves transmitted through the tissue.

Some patients might experience discomfort due to the sticky sensation from the application of ultrasound gel. Others might experience discomfort from the pressure applied to the probe under the imaging. Adverse effects, which we are not aware of, may exist. However, clinical ultrasound has existed since the 1950'ies and new adverse effects are unlikely.

Publication: All results will be published in international peer-review journals. Also in the event of inconclusive results.

Being tested
Point of Care Ultrasonography

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Point of Care UltrasonographyDevice

Study groups in NCT02099045
Study groupRoleWhat they receive
Ultrasound examinationAll patients over the age of 18 presenting in the emergency department.
Receives: Device: Point of Care Ultrasonography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pathology found by POC ultrasonography

    Cardiac function. Pericardial effusion more than 3 mm. Left ventricular function: Hyper dynamic, Normal, Mildly reduced, Moderately reduced, Severely reduced. Hypertrophic left ventricle: Ventricle wall > 1,2 cm Right ventricle function: TAPSE: > 20 mm: 16-20 mm: 13-15 mm: 10-12 mm: < 10 mm. Right ventricle wall > 0,8mm Left ventricle < right ventricle. Aortic sclerosis, Visible mass in lumen, Visible papillary muscle rupture, Pathology to mitral or tricuspid valve, Other findings. Inferior Vena Cava. IVC diameter : < 10 mm,10 -15mm, 16- 20mm, > 20mm IVC respiratory variation: collapse, > 50%, <50%, none Lung ultrasound: Absence of lung sliding, Visible pleural effusion, Multiple b-lines (≥3 in focal area) Abdominal ultrasound: Free fluid, Hydronephrosis: Left; Right, Gallbladder wall thickening > 4 mm Gallbladder width: > 4 cm,Murphey's sign, Visible cholecystolithiasis, Aortic aneurism: Size in cm Bladder size in ml Evaluation of the deep veins on the lower extremity for DVT

    Measured: Within two hours after initial evaluation of the patient.

Secondary outcomes (1)
  1. Changes in diagnostics or treatments plan

    Measured: Within 2 hours after primary evaluation of the patient after the ultrasound examination has been performed.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2014 (estimated)
  2. Study startApr 2014
  3. Primary completionNov 2015 (estimated)
  4. Study completionJan 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
406 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02099045
Sponsor's protocol ID
DNVK1305018
Status last verified
Jan 2015
First submitted
26 Mar 2014
Last updated
14 Jan 2015
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Point of Care Ultrasonography in the Emergency Department., run by Aarhus University Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Jan 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jesper Weile, MD ((+45)22748072, jesper.weile@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pathology found by POC ultrasonography (time frame: Within two hours after initial evaluation of the patient.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in